Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma.

Taken together, the resectable early-stage PDAC has unique metabolic features in serum and tissue samples. The defined panel of three metabolites has the potential value for early screening of PDAC at the resectable stage.